Biocept Stock Z Score
| BIOCDelisted Stock | USD 1.45 0.17 13.28% |
Biocept |
Biocept Company Z Score Analysis
Biocept's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
Current Biocept Z Score | -15.64 |
Most of Biocept's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biocept is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
| |||||||
| |||||||
| |||||||
| |||||||
|
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
CompetitionIn accordance with the company's disclosures, Biocept has a Z Score of -15.64. This is 331.7% lower than that of the Biotechnology sector and notably lower than that of the Health Care industry. The z score for all United States stocks is notably higher than that of the company.
Biocept Z Score Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biocept's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Biocept could also be used in its relative valuation, which is a method of valuing Biocept by comparing valuation metrics of similar companies.Biocept is currently under evaluation in z score category among its peers.
Biocept Fundamentals
| Return On Equity | -1.87 | |||
| Return On Asset | -0.52 | |||
| Operating Margin | (10.38) % | |||
| Current Valuation | 5.92 M | |||
| Shares Outstanding | 2.63 M | |||
| Shares Owned By Insiders | 9.20 % | |||
| Shares Owned By Institutions | 1.98 % | |||
| Number Of Shares Shorted | 29.73 K | |||
| Price To Earning | 5.34 X | |||
| Price To Book | 0.37 X | |||
| Price To Sales | 0.20 X | |||
| Revenue | 25.86 M | |||
| Gross Profit | (2.58 M) | |||
| EBITDA | (31.98 M) | |||
| Net Income | (32.09 M) | |||
| Cash And Equivalents | 27.57 M | |||
| Cash Per Share | 1.63 X | |||
| Total Debt | 12.11 M | |||
| Debt To Equity | 0.33 % | |||
| Current Ratio | 3.38 X | |||
| Book Value Per Share | 0.12 X | |||
| Cash Flow From Operations | (13.29 M) | |||
| Short Ratio | 0.05 X | |||
| Earnings Per Share | (48.17) X | |||
| Price To Earnings To Growth | (0.04) X | |||
| Target Price | 4.0 | |||
| Number Of Employees | 50 | |||
| Beta | 0.6 | |||
| Market Capitalization | 1.14 M | |||
| Total Asset | 30.87 M | |||
| Retained Earnings | (298.44 M) | |||
| Working Capital | 10.84 M | |||
| Current Asset | 9.64 M | |||
| Current Liabilities | 3.34 M | |||
| Z Score | -15.64 | |||
| Net Asset | 30.87 M |
About Biocept Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biocept's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biocept using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biocept based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Consideration for investing in Biocept Stock
If you are still planning to invest in Biocept check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biocept's history and understand the potential risks before investing.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |